SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

HC Wainwright & Co. Maintains Buy on Immunovant, Lowers Price Target to $23

HC Wainwright & Co. analyst Douglas Tsao maintains Immunovant (NASDAQ:IMVT) with a Buy and lowers the price target from $33 to $23.

05/10/2021 06:30
HC Wainwright & Co. analyst Douglas Tsao maintains Immunovant (NASDAQ:IMVT) with a Buy and lowers the price target from $33 to $23.